Comparing Treatment with Nebulized 3% Hypertonic Saline Versus Nebulized 0.9% Saline In Patients With Acute Bronchiolitis: A Double-Blind Randomized Controlled Trial
Objective: To establish the therapeutic role of nebulized hypertonic saline solution in the management of acute bronchiolitis in terms of primary and secondary outcomes. Methods: This randomized control trial was conducted in the Pediatric department of Holy Family Hospital, Rawalpindi for 8 mont...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Rawalpindi Medical University
2024-03-01
|
| Series: | Journal of Rawalpindi Medical College |
| Online Access: | https://www.journalrmc.com/index.php/JRMC/article/view/2335 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832086935824236544 |
|---|---|
| author | Uzma Abid Ayesha Afzal Nahdia Zaman Ammara Farooq Sidrah Yousaf Sonia Fazal |
| author_facet | Uzma Abid Ayesha Afzal Nahdia Zaman Ammara Farooq Sidrah Yousaf Sonia Fazal |
| author_sort | Uzma Abid |
| collection | DOAJ |
| description |
Objective: To establish the therapeutic role of nebulized hypertonic saline solution in the management of acute bronchiolitis in terms of primary and secondary outcomes.
Methods: This randomized control trial was conducted in the Pediatric department of Holy Family Hospital, Rawalpindi for 8 months from September 2021 to April 2022 after ethical approval. A total of 65 cases of acute bronchiolitis were enrolled who were divided into two groups. The intervention group was nebulized with 3 ml of 3% hypertonic saline 6 hourly while the control group was nebulized with 0.9% saline 6 hourly during hospital stay in addition to the standard treatment. Children in both groups were monitored in terms of clinical severity score, feeding, hydration status, length of hospital stay, duration of oxygen supplementation, development of any adverse effect, and outcome (length of hospital stay and clinical severity score) was observed. Data was collected on a predesigned proforma, and SPSS version 21 was used to analyze the data.
Results: Two groups were comparable for age, gender, and baseline characteristics including clinical severity score. Length of hospital stay was significantly less in the hypertonic saline group 75.53 ±43 .87 versus 45.92 ± 12.19 (p-value 0.000). Similarly, in patients requiring oxygen, treatment with hypertonic saline significantly reduced the duration of nebulization, 27.21 ±26.20 versus 10.67± 7.91 (p-value 0.03). However clinical severity score between the two groups was not different, 5.42 ± 2.88 in the saline group and 4.50 ± 2.88 p value 0.921.
Conclusion: Nebulization with hypertonic saline reduces oxygen requirement and benefits in reducing the length of hospital stay.
Keywords: Bronchiolitis, Hypertonic saline (HS), Normal saline (NS)
|
| format | Article |
| id | doaj-art-6b04061baa8d4ab8913b3e210bde40dc |
| institution | Kabale University |
| issn | 1683-3562 1683-3570 |
| language | English |
| publishDate | 2024-03-01 |
| publisher | Rawalpindi Medical University |
| record_format | Article |
| series | Journal of Rawalpindi Medical College |
| spelling | doaj-art-6b04061baa8d4ab8913b3e210bde40dc2025-02-06T08:39:40ZengRawalpindi Medical UniversityJournal of Rawalpindi Medical College1683-35621683-35702024-03-0128110.37939/jrmc.v28i1.2335Comparing Treatment with Nebulized 3% Hypertonic Saline Versus Nebulized 0.9% Saline In Patients With Acute Bronchiolitis: A Double-Blind Randomized Controlled TrialUzma AbidAyesha AfzalNahdia Zaman0Ammara FarooqSidrah YousafSonia FazalHoly family hospital Objective: To establish the therapeutic role of nebulized hypertonic saline solution in the management of acute bronchiolitis in terms of primary and secondary outcomes. Methods: This randomized control trial was conducted in the Pediatric department of Holy Family Hospital, Rawalpindi for 8 months from September 2021 to April 2022 after ethical approval. A total of 65 cases of acute bronchiolitis were enrolled who were divided into two groups. The intervention group was nebulized with 3 ml of 3% hypertonic saline 6 hourly while the control group was nebulized with 0.9% saline 6 hourly during hospital stay in addition to the standard treatment. Children in both groups were monitored in terms of clinical severity score, feeding, hydration status, length of hospital stay, duration of oxygen supplementation, development of any adverse effect, and outcome (length of hospital stay and clinical severity score) was observed. Data was collected on a predesigned proforma, and SPSS version 21 was used to analyze the data. Results: Two groups were comparable for age, gender, and baseline characteristics including clinical severity score. Length of hospital stay was significantly less in the hypertonic saline group 75.53 ±43 .87 versus 45.92 ± 12.19 (p-value 0.000). Similarly, in patients requiring oxygen, treatment with hypertonic saline significantly reduced the duration of nebulization, 27.21 ±26.20 versus 10.67± 7.91 (p-value 0.03). However clinical severity score between the two groups was not different, 5.42 ± 2.88 in the saline group and 4.50 ± 2.88 p value 0.921. Conclusion: Nebulization with hypertonic saline reduces oxygen requirement and benefits in reducing the length of hospital stay. Keywords: Bronchiolitis, Hypertonic saline (HS), Normal saline (NS) https://www.journalrmc.com/index.php/JRMC/article/view/2335 |
| spellingShingle | Uzma Abid Ayesha Afzal Nahdia Zaman Ammara Farooq Sidrah Yousaf Sonia Fazal Comparing Treatment with Nebulized 3% Hypertonic Saline Versus Nebulized 0.9% Saline In Patients With Acute Bronchiolitis: A Double-Blind Randomized Controlled Trial Journal of Rawalpindi Medical College |
| title | Comparing Treatment with Nebulized 3% Hypertonic Saline Versus Nebulized 0.9% Saline In Patients With Acute Bronchiolitis: A Double-Blind Randomized Controlled Trial |
| title_full | Comparing Treatment with Nebulized 3% Hypertonic Saline Versus Nebulized 0.9% Saline In Patients With Acute Bronchiolitis: A Double-Blind Randomized Controlled Trial |
| title_fullStr | Comparing Treatment with Nebulized 3% Hypertonic Saline Versus Nebulized 0.9% Saline In Patients With Acute Bronchiolitis: A Double-Blind Randomized Controlled Trial |
| title_full_unstemmed | Comparing Treatment with Nebulized 3% Hypertonic Saline Versus Nebulized 0.9% Saline In Patients With Acute Bronchiolitis: A Double-Blind Randomized Controlled Trial |
| title_short | Comparing Treatment with Nebulized 3% Hypertonic Saline Versus Nebulized 0.9% Saline In Patients With Acute Bronchiolitis: A Double-Blind Randomized Controlled Trial |
| title_sort | comparing treatment with nebulized 3 hypertonic saline versus nebulized 0 9 saline in patients with acute bronchiolitis a double blind randomized controlled trial |
| url | https://www.journalrmc.com/index.php/JRMC/article/view/2335 |
| work_keys_str_mv | AT uzmaabid comparingtreatmentwithnebulized3hypertonicsalineversusnebulized09salineinpatientswithacutebronchiolitisadoubleblindrandomizedcontrolledtrial AT ayeshaafzal comparingtreatmentwithnebulized3hypertonicsalineversusnebulized09salineinpatientswithacutebronchiolitisadoubleblindrandomizedcontrolledtrial AT nahdiazaman comparingtreatmentwithnebulized3hypertonicsalineversusnebulized09salineinpatientswithacutebronchiolitisadoubleblindrandomizedcontrolledtrial AT ammarafarooq comparingtreatmentwithnebulized3hypertonicsalineversusnebulized09salineinpatientswithacutebronchiolitisadoubleblindrandomizedcontrolledtrial AT sidrahyousaf comparingtreatmentwithnebulized3hypertonicsalineversusnebulized09salineinpatientswithacutebronchiolitisadoubleblindrandomizedcontrolledtrial AT soniafazal comparingtreatmentwithnebulized3hypertonicsalineversusnebulized09salineinpatientswithacutebronchiolitisadoubleblindrandomizedcontrolledtrial |